We are an ambitious cyanobacterial biologics platform company seeking an outstanding candidate for the role of Research Scientist.
As a highly-motivated individual, you will specialise in design, development, delivery and testing of novel cyanobacterial biologics, including monoclonal antibodies, VLP vaccines, & therapeutic proteins.
You will tackle a range of challenges as an integral part of the team, and demonstrate a high degree of flexibility, creativity, and initiative.
You will have team leadership experience, be adaptable, work well collaboratively, and be able to thrive in a start-up environment.
Key Responsibilities Development of genetic designs in collaboration with CTOCreation & execution of genetic design strategies, including: Design of genetic biologic expression components Design of plasmids; Management of build & verification process Management of cyanobacteria strain pipeline, including sequence verification Working with downstream processing lead to coordinate analysis pipeline Support in vitro & preclinical evaluation of biologics, in collaboration with R&D team & CTOUpdating CTO and Executive on status and timelines for biologics & preclinical material preparation Management of lab resources; overseeing smooth functioning of the strain engineering pipeline Managing preclinical material production, in collaboration preclinical testing collaborators Education & Experience Critical Ph.
D.
in Bioengineering, Synthetic Biology, Immunology, Microbiology, or closely-related area, Competent in microorganism design; hands-on experience with the latest genetic engineering tools, including multi-fragment DNA assembly, cloning, and prokaryotic transformation essential Advantageous but not essential: Industrial/postdoctoral lab experience within biotechnology, immunology, vaccine development or therapeutics Experience engineering cyanobacteria VLP, m Ab and therapeutic protein expression, purification, delivery or testing ELISA-based testing & in vitro/in vivo therapeutic characterisation Experience with mammalian cell culture & m Ab expression Conducted preclinical development studies of m Abs, vaccines or therapeutic proteins Experience using computational tools for protein design About the Company Bondi Bio is an Australian biotechnology company developing a novel platform for the biomanufacture and delivery of biologics using bioengineered cyanobacteria.
The platform offers a cost-effective and rapidly-scalable solution to produce monoclonal antibodies, vaccines, and therapeutic proteins.
Bondi's food-grade cyanobacteria has the potential for distributed biomanufacturing and point-of-care needle-free delivery.
